Multicenter observational study of fulvestrant 500 mg in postmenopausal Japanese women with ER positive advanced or recurrent breast cancer after prior endocrine treatment (SBCCSG29 study)

被引：0

作者：

Kimizuka, K. ^{[1
]}

Inoue, K. ^{[2
]}

Nagai, S. ^{[2
]}

Saito, T. ^{[3
]}

Nakano, S. ^{[4
]}

Futsuhara, K. ^{[5
]}

Sakurai, T. ^{[6
]}

Yamada, H. ^{[7
]}

Hata, S. ^{[8
]}

Kaneko, S. ^{[9
]}

Kurosumi, M. ^{[10
]}

机构：

[1] Kasukabe Municipal Hosp, Dept Breast Surg, Kasukabe, Japan

[2] Saitama Canc Ctr, Dept Breast Oncol, Saitama, Japan

[3] Saitama Red Cross Hosp, Dept Breast Surg, Saitama, Japan

[4] Kawaguchi Municipal Med Ctr, Dept Surg, Kawaguchi, Japan

[5] Jichi Med Univ, Saitama Med Ctr, Div Breast Oncol, Dept Surg, Saitama, Japan

[6] JCHO Saitama Med Ctr, Dept Surg, Saitama, Japan

[7] Sekishindo Hosp, Dept Surg, Kawagoe, Saitama, Japan

[8] Mitsui Hosp, Dept Breast Surg, Kawagoe, Saitama, Japan

[9] Saitama Cooperat Hosp, Dept Surg, Kawaguchi, Saitama, Japan

[10] Saitama Canc Ctr, Dept Pathol, Saitama, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

57PD

引用

页码：18 / 18

页数：1